Press Release 2013

Sabinsa Corporation’s Vice President, Scientific Affairs, Anurag Pande, PhD, will be speaking at the FI KOREA 2013 Conference which will be held on September 4 – 6, 2013 in Seoul, Korea. The conference is focused on food ingredients and food technology.

Dr. Pande’s topic, presented on September 5th, will be “BioPerine: The Natural BioEnhancer” in the session of Food Ingredients and Innovation, chaired by Dr. Jeong Min Lee, Prof.

 

FI KOREA 2013 is expected to attract approximately 15,000 participants from throughout the world including policy makers, key officials, researchers, related food ingredients-­‐industry executives and other experts. The conference topics will address all levels of food ingredient technology. For more information on FI KOREA 2013, please visit www.fikorea.org.

 

BioPerine Logo

    HEADQUARTERS

  • Unit no.1200, 2nd Floor,
    Citiview Building
    12 Mac Dinh Chi Street
    Dakao Ward, District 1
    Hochiminh City 700000
    Vietnam

  • +84(28) 3930 0341
  • +84(28) 3930 0342
  • info@sabinsa.vn

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.